NHS England faces 10,000 patient shortfall in cancer treatment target
NHS England is projected to miss its 2027 cancer treatment target by nearly 10,000 patients, with experts citing insufficient staff and equipment as primary causes.
By LAS News Desk · Published 15 Nov 2026, 11:19 WAT

NHS England is currently on a trajectory to miss a key interim target for cancer treatment by approximately 10,000 patients, according to an analysis of official figures. The government has set a goal to ensure that 80% of cancer patients begin treatment within 62 days of an urgent referral or consultant upgrade by March 2027. However, recent data indicates that the health service is significantly behind this pace, with experts warning that a lack of leadership, focus, and resources is driving the failure.
In September, the proportion of patients starting treatment within the 62-day window was recorded at 70.7%. This figure represents a decline from 71.9% in August, demonstrating a worsening trend as the deadline approaches. With fewer than 100 days remaining until the March 2027 target date, the gap between current performance and the required standard is widening. The analysis suggests that the NHS would need to treat 2,850 additional patients on time each month to return to the necessary trajectory, assuming that patient volumes remain consistent with current levels.
Calculations provided by the charity Radiotherapy UK indicate that 24,400 cancer patients per month would need to start treatment on time to achieve the 80% target. In contrast, the NHS is currently treating approximately 21,500 patients within the 62-day limit. This discrepancy results in a monthly shortfall of 2,850 patients, which accumulates to a total deficit of 9,490 patients over the remaining period. The data highlights a systemic inability to meet the volume required to satisfy the government’s interim objective.
Background
The interim target was established to improve the speed of cancer care in England, aiming for 80% of patients to receive treatment within 62 days of referral. The current performance metrics show a significant disparity between different types of cancer. While more than two-thirds of patients diagnosed with prostate and breast cancers are treated within the two-month timeframe, the situation is less favorable for other conditions. For instance, only 60.9% of patients with lung cancer are treated on time, indicating that specific cancer pathways are underperforming more severely than others.
Prof Pat Price, who serves as the chair of Radiotherapy UK and is a leading oncologist, has commented on the structural issues underpinning these figures. According to Price, the government is likely to miss the target because the NHS lacks the necessary staff and equipment to handle the current volume of patients. He attributed the shortfall to a lack of leadership, suggesting that this administrative failure has tangible consequences for patient outcomes. The charity’s analysis forms the basis of the projections regarding the cumulative shortfall, relying on consistent monthly patient volumes to model the gap.
Why it matters
The failure to meet the 62-day treatment target has direct implications for patient survival and health outcomes. Experts warn that the delay in treatment could lead to increased mortality rates, as patients do not receive care within the optimal window. Prof Price stated that thousands of people could die as a result of not receiving treatment on time, linking the resource shortage directly to potential loss of life. The disparity in treatment times across different cancer types, such as the lower percentage for lung cancer compared to breast and prostate cancer, suggests that some patient groups are disproportionately affected by the current system's inefficiencies.
The situation reflects broader concerns about the NHS’s capacity to deliver on its strategic goals. The reliance on interim targets suggests that the health service is struggling to maintain momentum in cancer care. The identified shortfall of nearly 10,000 patients is not merely a statistical anomaly but represents a significant portion of the annual cancer population in England. The warning from experts highlights a crisis in resource allocation and leadership, where the availability of staff and equipment is insufficient to match the demand for timely cancer treatment.
What happens next
The March 2027 deadline is the immediate next milestone for the NHS in meeting this specific interim target. To close the gap, the health service would need to increase the number of patients treated on time by 2,850 per month. However, the sources do not provide details on specific measures the government or NHS England plans to implement to address the staff and equipment shortages. The current trajectory, based on September data, indicates that without significant intervention, the target will not be met. The ongoing monitoring of monthly figures will determine whether the shortfall continues to accumulate or if corrective actions are taken in the final months before the deadline.
Sources
Spotted an error? · Corrections policy
Related stories

American Cancer Society recommends biennial PSA testing for average‑risk men aged 50‑69
The American Cancer Society has reversed its 2010 stance, urging men 50 to 69 with average risk to undergo prostate‑specific antigen screening every two years, while high‑risk groups are advised to start annual testing at age 45.
Photo: U.S. Army photo by Sgt. Austin Robertson / Wikimedia Commons · Public domain
LAS News Desk · 13 Nov 2026, 06:44 WAT · 4 sources

Wales plans ban on energy drinks for under-16s following England's move
The Welsh government is considering prohibiting the sale of high-caffeine energy drinks to under-16s, a move supported by young people and experts but opposed by the soft drinks industry.
LAS News Desk · 7 Nov 2026, 08:10 WAT · 2 sources

Global Microsoft outage disrupts UK NHS, schools, and police services
A widespread failure in Microsoft 365 services caused significant disruption to healthcare, education, and law enforcement in the UK, forcing staff to revert to manual processes.
LAS News Desk · 14 Nov 2026, 21:46 WAT · 2 sources

Women with cancer report treatment‑induced menopause and call for better support
Breast‑cancer survivors in the UK say chemotherapy and surgery have triggered early menopause, prompting calls for clearer information and services, as the Department of Health pledges to include menopause in cancer‑care plans.
LAS News Desk · 8 Nov 2026, 19:17 WAT · 1 source

Cocaine consumption in England rises 26% as linked crimes surge
New Home Office data indicates a 26% increase in cocaine use in England between 2021 and 2025, coinciding with a 10% rise in associated crimes since 2019.
LAS News Desk · 25 Oct 2026, 13:46 WAT · 2 sources

Pope Leo XIV’s lung cancer surgery ends need for further treatment
Vatican doctors confirm Pope Leo XIV's lung cancer is localized and requires no further therapy. The 71-year-old pontiff has resumed public duties following his discharge from Gemelli Hospital.
Photo: Edgar Beltrán , The Pillar / Wikimedia Commons · CC BY-SA 4.0
LAS News Desk · 1 Nov 2026, 14:16 WAT · 12 sources
More Health news ›
- Virginia reports first measles-associated child death of 2026
- Senate health panel blocks Trump‑nominated Jim O’Neill from leading the National Science Foundation
- FDA shelves Trump‑era fast‑track drug review programme
- Public‑health‑focused candidates win US midterms as voters react to disease outbreaks
- New York declares disaster emergency after child dies from measles, first fatality in three decades